Performance overview
Value at beginning of month: $121,630.83
Value at end of month: $148,917.34
Month over month change: +22.43%
Total IRR: 20.51%
Related indices, monthly change
NASDAQ: +6.01%
IVV (iShares Core S&P 500): +6.32%
IBB (iShares NASDAQ Biotechnology Index): +7.32%
MXI (iShares Global Materials): +4.68%
VEGI (iShares MSCI Global Agriculture Producers): +1.37%
ICLN (iShares Clean Energy): +5.68%
Individual performances
Another great month for the index, we saw several huge news events leading to large increases in value for certain companies. Spark Therapeutics led the group when it was announced that they will be acquired by Roche. This news also lifted the value of a number of other medical stocks, as gene therapies continue to drive value. Amyris also had a huge jump on news of a major partnership for the production of cannabinoids. Intrexon, on the other hand, fell over 30% after a disappointing quarter.
Changes made to index
Spark Therapeutics was removed due to their acquisition.
You can view the index here.
Allocation as of March 1, 2019
